MSD Animal Health has launched Bovilis IBR Marker Inac, an inactivated marker vaccine for use in the control of Infectious Bovine Rhinotracheitis (IBR).
The company says the new product complements Bovilis IBR Marker Live and creates a range now offering greater simplicity and additional flexibility for veterinary surgeons seeking optimum control protocols for their clients' herds.
MSD Animal Health ruminant veterinary adviser Drew McGurren MRCVS said: "Farmer compliance is an important part of any successful vaccination programme. With this extended Bovilis IBR Marker programme, farmers can now start IBR vaccination of their cattle from three months of age with a single shot primary course of Bovilis IBR Marker Live, easily followed by boosters every six months using a single dose of either Bovilis IBR Marker Live or Bovilis IBR Marker Inac. Both primary course and boosters can be administered by the same intramuscular route.
"Alternatively, Bovilis IBR Marker Inac can be administered to cattle from three months of age as a primary course of two injections four weeks apart. The programme then follows a six monthly single dose booster regime.
"The availability of Bovilis IBR Marker Inac provides a simple control option in defined farm situations, not least where an alternative to the live vaccine is preferred or required. Overall, we see this development adding convenience, ease of use and flexibility for veterinary surgeons as they work with their clients to control a significant disease threat in dairy and beef cattle in the UK."
Bovilis IBR Marker Inac is a prescription-only medicine (POM-V). The product is available from wholesalers now in 10 and 50 dose vials. For further information, contact the MSD Animal Health Veterinary Support Group on 01908 685685.
The Kennel Club and dog breeding world still needs to take urgent action to improve the health and welfare of pedigree dogs, five years after a BBC documentary highlighted the levels of suffering many animals endure, according to the RSPCA.
Programme maker Jemima Harrison, who produced and directed Pedigree Dogs Exposed, has backed the RSPCA's call for urgent action.
She said: "Five years on from Pedigree Dogs Exposed, the Kennel Club is still in denial about the extent of the problems.
"It is unethical to continue to breed dogs like Pugs and Bulldogs which have such flat faces that they cannot breathe - and yet the Kennel Club registers these breeds in their growing thousands and these dogs continue to be celebrated at Kennel Club shows.
"The Kennel Club has done too little to tackle the suffering these and many other breeds endure, despite an increasing amount of science which both articulates the issues and offers solutions. The dogs continue to pay a huge price."
The RSPCA has acknowledged the progress made by the Kennel Club and dog breeders, including the development of DNA and health screening tests for hereditary diseases and the introduction of veterinary checks on 'high profile' breeds.
However, the charity says it believes much more should have been done in the five years since Pedigree Dogs Exposed was first broadcast on BBC One in 2008.
RSPCA chief vet James Yeates said: "Although some progress has been made by the dog world to address the issues raised in Pedigree Dogs Exposed, it has not been nearly enough. Five years on the problems are still far from being solved.
"We are concerned that many pedigree dogs are still suffering because they're bred and judged primarily for how they look rather than with health, welfare and temperament in mind.
"We believe that meaningful action is urgently needed in order to make a real improvement to the welfare of pedigree dogs."
Some of the changes the RSPCA is calling for include:
The RSPCA's Born To Suffer campaign and petition was launched more than 18 months ago, with a call to change breed standards so that they prioritise the health, welfare and temperament of a dog over its looks. It is hoped this will put an end to the avoidable suffering many dogs endure.
You can still sign the petition by visiting www.rspca.org.uk/borntosuffer
International Cat Care (formerly the Feline Advisory Bureau) is once again raising the issue of cats accidentally poisoned by dog flea products containing permethrin.
The charity is undertaking a campaign to warn owners of the dangers of using dog flea products on their cats because cats are still dying unnecessarily. While the incidents outlined here occurred in the UK, previous reports have shown that this is the most common cause of poisoning of cats in many countries because products are widely and easily available.
Gary Rutland RVN DipAVN(Surgical), Head Nurse and Cat Advocate at the Cat Friendly Millennium Veterinary Practice in Essex was moved to get in contact with International Cat Care after the death of a nine-week-old kitten treated with a permethrin-containing dog spot-on bought at a local pet store. Understandably, both the owners and the practice staff were greatly distressed. The owner used it on her dog and, because it was cheap, assumed it would 'not be strong' and would be fine to use on the kitten. A video of the kitten on the ICC website (www.icatcare.org/permethrin/cat-deaths) shows the resulting seizures.
The second incident concerned two 7-year-old cats treated accidentally after Donna, their owner, bought a dog spot-on containing permethrin from a local shop without wearing her glasses. Someone had placed a dog treatment among the cat treatments and she picked it up. No advice was given to Donna in the shop. She said that the flea treatments were on the shelves, 'just like selling smarties in a children's candy store'.
Although both products had a warning on the packaging, this was either not seen or not taken seriously enough because such products are so freely available and nobody thinks that a drop of a dog product could kill their cat.
International Cat Care is demanding that dog spot-on flea products containing permethrin should not be available without verbal advice at the point of sale. Currently these products are categorised by the Veterinary Medicines Directorate (VMD) in the UK as AVM-GSL, which means that they can be bought directly off the shop shelf without the need for advice. The charity says they should be recategorised as NFA-VPS so that they can only be purchased if there is someone in the shop who is suitably qualified to speak to and advise the buyer. The shop should advise that they are only for use on dogs, and ask if there are any cats in the home which could come into contact with a recently-treated dog. The owners can then be warned to keep the dog and cat apart, or advised to use a different product. Advice must be given with some other current non-permethrin containing spot-on products sold through pet shops under the NFA-VPS authorisation and many of these products have a much safer profile if used accidentally on cats, than those containing permethrin.
Dr Andy Sparkes, Veterinary Director for International Cat Care, said: 'Many practices see permethrin poisoning in cats several times a year but do not contact the VMD because the product is not a POM or they feel that the Directorate already knows about the problem. We feel strongly that the problem is greatly under-reported. Nothing will be done unless the full extent of the problem is realised by the VMD, so please report each one by going on the website at https://www.vmd.defra.gov.uk/adversereactionreporting/. These cat deaths are totally preventable - you can sign our petition at www.icatcare.org/permethrin/petition to change the categorisation.'
The charity is also asking the pet trade to voluntarily class these dog spot-on products containing permethrin as NFA-VPS and to provide advice to their customers accordingly. Pets at Home is working with International Cat Care and the company will be adding a till prompt so that the product cannot be sold without customers being asked whether they have a cat and given appropriate advice.
Maeve Moorcroft, Head of Pets at Pets at Home which earlier this year launched its Flea Fight Force said: 'We take the risk of permethrin poisoning in cats very seriously. We are introducing prompts at our tills so that customers are asked during the checkout process if they are aware of the risk to cats in the home when purchasing a permethrin based spot-on dog flea treatment, and also advised to wait at least 72 hours after treating the dog before the dog and cat can come into close contact.'
International Cat Care is urging veterinary practices to ensure that if concentrated permethrin-containing spot-on products are prescribed and dispensed for use on dogs, adequate warnings are given, including when owners come in for repeat prescriptions. Asking if there is a cat in the house each time a product is dispensed is critical in case a cat has recently been added to the home.
Information on the veterinary treatment of permethrin poisoning cases can be found on the ICC website at www.icatcare.org/permethrin/vet-info
Bayer Animal Health, makers of Profender, has launched a campaign to reignite the age-long debate, 'Cats vs Dogs', to highlight the importance of protecting cats against intestinal worms.
Aiming to spark discussion between pet owners and vets, the campaign emphasises key differences between cats and dogs, including the challenges they present when it comes to worming control, such as cats' independent nature.
Previous research by Bayer Animal Health found that 42% of cat owners worry their pet does not swallow worming tablets, 38% are concerned that it will spit it out and 21 per cent say their cat runs away. This leaves potentially more than 750,000 cats unprotected from the parasite.
Launching in September, the campaign microsite http://www.catsvdogs.co.uk/, invites the public to vote for who they think rules, while uniting and educating owners over their common foe: intestinal worms. Voting closes at the end of November, with a tribute video to the winning species as voted for by the nation.
Alongside the microsite, a nationwide survey of pet owners is being conducted in partnership with Your Cat and Your Dog magazine to uncover pet owner perceptions of cats vs dogs, including parasite protection attitudes.
Campaign materials will also be supplied to veterinary practices, including an educational poster about worming control and applying spot-ons. For further information and campaign materials please get in touch with your local Bayer Animal Health Territory Manager.
For further information about Profender, or parasite control in companion animals, visit: http://www.itsajungle.co.uk/.
Animalcare has unveiled its new logo, introduced to mark the latest stage in the company's development which has seen it move into larger offices and upscale its warehouse facilties to better serve the profession.
The new logo consists of three flags, each representing one of the three core pillars of Animalcare; veterinary pharmaceuticals, companion animal electronic identification and animal welfare. The three flags combine to make a stylized 'A' and the motif as a whole with the word 'Animalcare' combines to make the new logo.
Mindful of the environment, Animalcare says there will be a phased roll-out of the new logo across the customer facing elements of Animalcare. This will begin with the new price list and will extend across the range of packaging, starting with Vitofyllin, and the marketing literature.
To request your new price list either as a PDF or printed copy, e-mail: info@animalcare.co.uk or speak to your local representative.
Merial has launched Merilym 3, the first Lyme disease vaccine available in the UK.
Lyme disease is the most common vector-borne disease in Europe and there has been an increase of over 300% in the number of reported human cases in the UK since 20011. Caused by infection with bacteria from the Borrelia burgdorferi group, the disease is transmitted by Ixodes spp. ticks.
Merial says the vaccine contains inactivated antigens from Borrelia burgdorferi sensu stricto, Borrelia afzelli and Borrelia garinii, so provides broad spectrum immunity against infection. Vaccination with Merilym 3 induces high levels of antibodies against a key bacterial antigen, which are ingested by the tick during blood feeding and subsequently bind to the bacteria in the tick gut, reducing the risk of transmission from the tick to the host.
For use in dogs, the vaccine can be administered to puppies from 12 weeks old, with a primary vaccination course of two injections, three weeks apart, followed by annual boosters. It is available in packs of 10 doses.
For more information, speak to your local Merial Territory Manager.
Reference
Ceva Animal Health has launched a new TV advertising campaign to raise awareness of the benefits of the veterinary behavioural product, Feliway.
The new advertisement, features the new 'Feliway' purple cat playing happily in the home with its family.
The advertisement will appear on the major UK channels including More 4, E4, ITV 1, Sky Channels and the Discovery Channel for one week from 16th September 2013, with an additional three weeks coverage during October 2013. Behind the scenes' footage of the filming of the advertisement can also be viewed on the Feliway YouTube Channel: http://www.youtube.com/channel/UCtAXd5mReYc6JGufxRirvng?feature=watch
A Feliway video on demand and YouTube campaign will be available to viewers between 16th September 2013 and 21st October 2013 and will be repeated between 15th November 2013 and 2nd December 2013.
An Adaptil video on demand campaign will be aired between 21st October 2013 and 11th November 2013 to raise awareness of Adaptil in the run up to and during the firework season. The video on demand will be available across ITV player, Sky Anytime On Demand, 4oD and YouTube.
For more information, call 01494 781510 or contact your local Ceva territory manager.
MSD Animal Health has reintroduced Zanil, the flukicide drench for cattle and sheep.
Based on the active ingredient oxyclozanide, MSD says Zanil is highly effective against the adult fluke responsible for chronic disease and - significantly for dairy farmers - is licensed for use in young, pregnant and lactating animals, with a 72-hour milk withhold period where milk is produced for human consumption.
MSD Animal Health veterinary advisor Matt Haslam said: "The latest independent data1 confirms that fluke is on the increase in UK cattle and sheep. The fluke problem is longstanding, but is being exacerbated by recent wet summer and autumn periods that have created ideal conditions for this parasite to proliferate and infect grazing livestock.
"Chronic liver fluke causes serious economic losses for livestock farmers. In dairy herds, for example, there will be a negative impact on fertility and milk production where cows are affected.
"It is important that farmers have access to the best treatment options given the size of the threat and the scale of potential losses. Zanil is used widely and effectively in Ireland in the control of fluke problems, and there is no known resistance to the active ingredient oxyclozanide. With its re-introduction into the country, we believe Zanil is unique as a flukicide-only treatment that is licensed for use in lactation and in the dry period for the treatment of adult fluke in dairy cows."
Zanil is an oral drench with POM-VPS authorisation, available from both animal health suppliers and veterinary practices. Dosage rate is 3ml per 10kg bodyweight in cattle, up to a maximum of 105ml, and 4.5ml per 10kg bodyweight in sheep, up to a maximum of 20ml.
See DEFRA emerging threats reports in sheep and cattle, Q1 2013: www.defra.gov.uk/ahvla-en/files/pub-survrep-sr0113.pdf
SureFlap, a microchip pet product company, will be launching SureFeed, a new automatic cat feeder at the London Vet Show, Stand L32, on the 21st - 22nd November 2013.
The company, which already sells a range of microchip-operated pet doors, says the new products are designed to keep food fresh and the kitchen free of smells and flies.
SureFeed will be available in two models: the SureFeed Pet Feeder, which opens when any pet approaches, and the SureFeed Microchip Pet Feeder which in addition functions as a selective pet feeder that opens only when it identifies a cat with a registered microchip or RFID collar tag.
Both products feature a bowl which seals shut to keep wet food fresh.
Dr Nick Hill, inventor of SureFeed as well as founder and inventor of SureFlap says this is an exciting new development for the company: "Many cats are fussy eaters and prefer to eat food when it is fresh, others are on special diets and this can be a problem in multi-pet households. Even in households where each cat is on the same diet, a 'greedy' cat, or even dog, can eat most of the food. This can result in one pet becoming overweight while the other starts to lose condition. The SureFeed product range has been designed to address all these issues."
The SureFeed Microchip Pet Feeder recognises a cat's unique microchip number and when an authorised cat is present, the sealed lid over the bowl slides back to reveal the food. Once the cat has left the feeder, the lid slides back over the bowl. The SureFeed Pet Feeder features the same sealed lid which is triggered to open by any approaching pet, closing again when the pet has finished feeding.
Nick said: "The SureFeed product range is the culmination of two years' intensive development work. The feeders incorporate a number of features to maximise usability, such as the Microchip Pet Feeder's side guards and lid which folds up to the rear, which shield the food from other pets while the authorised cat is eating. The feeders are both easy to wipe clean and the food bowl, mat and lid can be removed and are dishwasher-safe.
"The SureFeed Pet Feeder and Microchip Pet Feeder are the first in a suite of pet feeding products from SureFlap incorporating sealed operation and flexible feeding options and we are looking forward to developing the range in the future."
SureFeed products will be available to order from early 2014 but in the meantime, you can see them in action at Stand L32 at the London Vet Show.
Invicta Animal Health has announced that that EquiChek test kits are now validated for use with synovial fluid, having originally been validated for whole blood only.
EquiChek is an animal-side test to assess the level of Serum Amyloid A (SAA) which is a major acute phase protein of inflammation in horses.
Invicta says that it has been shown that SAA levels in synovial fluid are not influenced by arthrocentesis*, which makes SAA an ideal biomarker to measure whilst monitoring or assessing joint function.
The company says this is the first test which is able to provide a visual semi-quantitative result within 15 minutes. The test will display 4 lines for a normal level of SAA and sequentially fewer lines depending on the severity of the inflammation.
Rob Watkins, Managing Director of Invicta, said: "EquiChek has proved to be a useful tool in the ambulatory toolkit. The validation of synovial fluid extends the use by allowing real-time monitoring of lameness and intra-articular therapies. Normally whilst medicating joints, excess synovial fluid is discarded. Now this can be utilised to assist diagnosis or to assess the response to medication."
Invicta will be at Stand A16 BEVA Congress 2013.
For further information see www.invictavet.com/ or ring 01403 791313
The Pet Advertising Advisory Group (PAAG), which is comprised of representatives from the UK's leading animal welfare organisations, has launched a set of minimum standards for websites that advertise pets for sale.
PAAG says the new standards have been developed to improve the welfare of the pets and to protect members of the public from the risk of ending up with sick, dangerous or even illegal animals. The standards have also been endorsed by Defra and Lord de Mauley, the Minister for Animal Welfare, who has been discussing the need for improvement with the leading online pet classified websites.
The Group points to Kennel Club research which shows that one in five puppies bought online are dying before they reach six months, together with some of the worst adverts the organisation has seen online, as evidence for the urgent need for these new standards:
PAAG says it is working with the Government to remind consumers and websites that an animal is not a commodity like a washing machine or a car, and should not be advertised or bought in the same way. Websites in compliance with the standards will be identifiable to consumers on the PAAG website as the ethical and safer choice when deciding to find a pet online. The group is encouraging the public to stay vigilant to ensure that websites meet the standards consistently, and not to use sites that don't apply the Minimum Standards.Caroline Kisko, Secretary of the Kennel Club, said: "Whilst we recognise that puppies are commonly advertised online, it is still shocking to know that there are between 100,000 and 120,000 pet advertisements appearing on UK websites each day. The research undertaken by PAAG has revealed some truly terrible examples where animal welfare was clearly the last thought in the mind of the advertiser. Every day we hear from people who have bought a puppy online only for it to fall sick or die soon after, and the Kennel Club's research for its Puppy Awareness Week shows that one in five pups bought online die before they're six months old. "We hope that the Minimum Standards will be just that, a minimum standard that a website must reach before posting advertisements for pets. In an ideal world we would prefer people not to buy pets online but would advise that if you are doing so that you check the website adheres to PAAG's Minimum Standards. We urge people to go to a member of the Kennel Club Assured Breeder Scheme if they want the best chance of getting a healthy and well cared for puppy, as this is the only scheme in the country that sets standards for and monitors breeders."
Lord de Mauley, Minister for Animal Welfare at the Department for Environment, Food and Rural Affairs, said: "It is vitally important that advertising websites do all they can to ensure the welfare of animals sold on their sites and to prevent the sale of banned breeds. I fully support PAAG's Minimum Standards and would encourage all advertising websites to sign up to these."
PAAG says that the Minimum Standards are just the first step to improving how pets are advertised online, and that it will work closely with websites including Gumtree, Loot and Preloved to provide support on the reporting of suspicious adverts and the moderating of such ads. A team of volunteer moderators will also be created to provide further support for the websites and ensure that if anyone is turning to the internet to buy an animal they can do so with more confidence that they are buying a healthily bred pet.PAAG has compiled a video of case studies showing the impact of inappropriate online advertising on members of the public, the veterinary profession and animal welfare authorities. See: http://www.paag.org.uk.
PAAG comprises: Battersea Dogs & Cats Home, Blue Cross, British Veterinary Association, Cats Protection, Dogs Trust, The Kennel Club, Ornamental Aquatic Trade Association (OATA), One Kind, PDSA, RWAF, Raystede, Reptile and Exotic Pet Trade Association (REPTA), Wood Green the Animals Charity, World Horse Welfare.
The National Office of Animal Health has released two films to help industry and consumers understand issues surrounding the use of animal medicines in the food chain.
A film made for the food chain industry titled "Animal Medicines in Food Production - The Food Industry Perspective" has been produced to help industry understand the levels of awareness and concerns that consumers have.
A second film, "Animal Medicines in Food Production - Challenging the Myths" is aimed at consumers and looks at some of the myths surrounding the use of animal medicines in livestock production.
Phil Sketchley, Chief Executive of NOAH, said that while the public was generally supportive of the use of animal medicines in farm production, there was a knowledge gap among consumers about the way that medicines were used: "It was interesting to discover how much people knew about medicines in food production. There were some very positive attitudes among consumers, particularly towards the way British farmers care for their animals. But there were still some areas of concern, for example with the belief among a large number of people that growth hormones were still being used on UK farms, despite the fact they have been banned since 1988.
"The industry film should help people involved in food production understand what consumers are thinking when it comes to animal medicines. Animal health and welfare and ensuring sick animals are treated is a big issue, and food producers and retailers need to be able to communicate clearly with consumers on the subject of animal medicines.
"It is important there is transparency on all issues of animal health and welfare."
BCF Technology has launched a competition to win a top of the range digital radiography system from its Cuattro range for 6 months.
To enter the competition, you need to record a short video (up to 2 minutes) explaining how the DR system would transform your imaging function. BCF is asking entrants to be as creative as possible as the voting will be open to the public. The company will pick a shortlist of finalists and then invite the public to vote for a winner on its Facebook page and website.
The competition is open to both small animal and equine vets, for the following systems:
Sarah O'Grady from BCF said: "Having a Cuattro DR system could make a huge difference to either a small animal or an equine practice. For a small animal vet practice that doesn't currently have a DR system, they will love the difference it makes to X-ray studies. Diagnostic images are produced in seconds and re-takes are almost non-existent. A Wireless Slate 3+ can greatly improve the ease of in-stable operations and procedures. With the removal of wires, these procedures run much smoother. You will also be surprised by the improvement in image quality."
The closing date for the competition is 30th November 2013.
To enter your video:
The winner will be required to arrange insurance for the system during the time they have the system. Full terms and conditions can be found on the BCF website.
To find out more visit the BCF website or Facebook page or call +44 (0)1506 460 023.
Bayer Animal Health has launched a free mobile app for pet owners, offering a bespoke parasite treatment reminder service, to help them follow their parasite protection plan prescribed by their vet.
The app was launched following a survey that found that 65% of pet owners do not regularly use parasite treatment products and are not certain that their pet is adequately protected against fleas, ticks, lice, mites and intestinal worms1. In addition, 83% of owners do not realise full protection against parasites requires a combination of two or more treatment products, and 45% are not confident that they have the job under control2.
The app allows owners to develop an on-going parasite protection plan in line with their veterinary prescription and receive automated reminders on treatment dates. In addition, the app allows users to set reminders for vaccination boosters, other vet appointments, and entering special dates like their pet's birthday or grooming appointments.
Once downloaded, users can create a pet profile to keep track of all their information in one place, including breed details, microchip number, weight, and date of birth of their dogs, cats, rabbits and ferrets. A 'learn' section of the app is also available to provide owners with the general information about parasites and the risk they pose to pets and family members.
The Jungle for Pets app is initially available to download for iPhones and iPads, by searching 'Jungle for Pets' in the Apple App store or clicking here.
VetSurgeon downloaded the app to try it out. A very polished app which has the potential to be extremely useful for those of us that can't remember our own names, let alone when the dog is due to be wormed. Three problems we found, which will doubtless be ironed out in future updates: Firstly, whilst the app works on an iPad, it's sized for and looks better on an iPhone. Secondly, it demanded a photo of the dog for registration. Whilst that's easy enough to do with an iPhone, the app then froze when we tried. Perhaps it should be optional. Finally, whilst the app very usefully allows for reminders of non-Bayer products, it doesn't appear to allow the user to type in the name of the product, forcing it to be listed as 'other'. We suspect that anyone who can't remember treatment dates (probably most of us) also won't be able to remember what 'other' was, especially if there are more than one or two 'other' products.
References
The Webinar Vet has launched a new Scholarship membership which offers final year vet students unlimited access to its CPD webinars.
Webinar Vet founder, Anthony Chadwick MRCVS said: "We wanted to put something back into the profession and this seemed the ideal way to do so.
"All final year UK and international students are eligible to sign up, free of charge, for our small animal Platinum Membership - there are no hidden catches! This will give access to our weekly clinical webinars, practice management and nurse webinars as well as the huge archive of previous webinars to watch at their leisure or when they need information on a specific topic.
"Following a tremendous response at SPVS final year student conference over 100 have signed up so far. As well as the webinars students also receive regular blogs, e-newsletters and Platinum discounted rates on all additional specialist webinars. We also welcome international vets too as part of our mission of making high quality affordable CPD accessible to vets worldwide - and you can't get more affordable than free!"
For free membership go to http://thewebinarvet.com/studentscholarship or contact the Webinar Vet on 01513 240580.
Norbrook Laboratories has launched Noroseal, a new teat sealant containing a unique anti-infective ingredient.
The company says that Noroseal, a 2.6g intramammary suspension, is the only teat sealant in the market-place in Europe to contain a PVP-Iodine excipient.
Dr Barry McInerney MVB, MRCVS, PhD, Norbrook GB Veterinary Advisor said: "Noroseal, with its unique formulation, offers vets a proven barrier against intramammary infections during the dry period.
"New bacterial infections occur most often during the first three weeks of drying off because the cow's natural keratin plug is not completely formed. Indeed, approximately 50% of teat canals are still open for up to seven days after drying off. Noroseal Teat Sealant will mimic the cow's keratin teat barrier offering immediate protection against infection. Additionally, the anti-infective ingredient, PVP-Iodine, complements the effectiveness of the teat-sealant components in the teat canal barrier."
Norbrook says that the estimated annual cost of mastitis to the UK dairy industry is in excess of £168M with a single case of clinical mastitis costing farmers approximately £178.00 per cow.
Dr McInerney added: "Clinical mastitis is a costly business but one that can be avoided if timely action is taken. There are various treatments available for dealing with mastitis but studies have shown that the risk of clinical mastitis may be reduced by up to 50% by using a combination of teat sealant and dry cow intramammary therapy. Noroseal is therefore an ideal combination with Norbrook's dry cow therapies such as Noroclox DC, Bovaclox DC Xtra and Bovaclox DC."
Noroseal is available in packs of 24 or buckets of 120 units. A range of promotional material is also available to veterinary practices via the Norbrook Sales Team.
Bayer Animal Health, maker of Advantage, has produced a new animation to educate pet owners about fleas.
The three minute animation, which is available on YouTube (below), is also available from Bayer for practices to play in the waiting room.
For a copy of the animation, contact your local Bayer Animal Health Territory Manager. More information is also available at http://www.advantagespoton.co.uk/.
The University of Bristol's School of Veterinary Sciences at Langford has opened a £2 million state-of-the-art dairy farm.
Wyndhurst Farm's dairy unit has undergone a major rebuild in order to provide a world-class practical teaching environment for around 600 veterinary students, as well as a facility that can be used to support research and the continual professional development of veterinary surgeons, farmers and others involved in the dairy industry locally, nationally and internationally. Professor Jo Price, Head of the School of Veterinary Sciences, said: "This is an exciting time for the Vet School. The new dairy unit will enable our undergraduate and postgraduate students to be taught in a world-class facility. It will provide the best standards of animal welfare for our dairy herd and will support our research on the prevention and treatment of diseases of farm animals."The farm, which is approximately 250 acres, includes numerous features to ensure high welfare standards. The dairy herd will be housed in deep sand bedded cubicles, with parts of the floors covered in soft rubber to protect the cows' feet and when housed cows will be fed a total mixed ration using grass, maize and whole crop wheat silages grown on the farm.Since the new facility has been built the farm's herd of Pedigree Holstein cows have increased in number from 110 to 180 cows and will soon reach 200, with each cow giving over 9,000 litres of milk per year. The farm also has a newly established breeding flock of 100 New Zealand Romney ewes. Since 2010 it has been managed by Velcourt Farm Management.
The Goddard Growlers are putting the final touches to their training ahead of the Vet Charity Challenge event which takes place at Pershore College in Worcestershire on 28 September.
The team comprises Stone Lion Head Vet Roger Bralow; Practice Manager for North West London, Adrian Hayter; Philippa Davis, Regional Manager for NE London and Lisa Cooper, VN and Hospital Manager for Wanstead Hospital.
Philippa Davis said: "Our training regime is going well despite the injuries we've sustained making us consider that we might be 'too old' for this malarkey. I've certainly had to stop saying 'I don't do' running as I've found that I'm enjoying it and will continue to do it after the challenge. We make a great team and while the events will be very tough, we'll have some laughs along the way.
We certainly have a will to win and our fellow teams will find us highly competitive and growling at them at every opportunity! Seriously though, we're all really looking forward to it and watching the long range weather forecast with unusual interest! We're also delighted to be helping the fantastic causes which the Vet Charity Challenge is fundraising for this year. Our colleagues across the Goddard Group are giving us great support and we have already raised more than £600. Bring it on!"
The Growlers' progress can be followed by 'liking' their facebook page, 'Goddard Growlers', which also provides links for anyone wanting to support them with sponsorship. Alternatively, donations can be made at http://uk.virginmoneygiving.com/team/goddardgrowlers
Freelance Surgical Ltd has announced that it is now the sole UK distributor for IMEX Veterinary, Inc. external fixation products.
In fact, Freelance Surgical has been a supplier of IMEX products for over a year, but says that most customers had been buying from Animalcare, which has now ceased selling the products.
The company says external fixation is an effective method of orthopaedic fracture repair which has gained popularity in recent years. An external skeletal fixator (ESF) can be used as a primary fracture fixation device or to enhance stability provided by another primary fixation product. In some cases and when used correctly, the company says they can have a number of advantages over other fracture repair techniques.
The IMEX Veterinary, Inc. product portfolio includes an array of external skeletal fixation components, intramedullary pins, K-wires, orthopaedic wire and other related veterinary products. The modular ESF system is comprised of linear, hybrid and circular fixation with linear components common to all three and instrumentation interchangeable between the hybrid and circular external fixation systems.
James Towler, Veterinary Director at Freelance Surgical Ltd has received professional training with IMEX Veterinary, Inc. to ensure the UK market has access to up-to-date product and ordering information.
For more information contact Freelance Surgical Ltd on 0845 050 4147.
Virbac has announced that Canine Prostate Awareness Month, its initiative to highlight the prevalence of Benign Prostatic Hyperplasia (BPH), will be running again in November, and is urging practices to join in.
The initiative is timed to coincide with Movember, the fundraising initiative for male prostate disease and testicular cancer. Virbac says it hopes CPAM will remind owners that men are not the only ones to suffer from prostate disorders. Indeed, more than 80% of entire male dogs over the age of five are thought to suffer from BPH1.
As part of CPAM, Virbac is providing participating practices with promotional materials including owner educational and display materials, a template press release for local media, and free branded slip leads to pass on to owners who have had their dog checked.
Chris Geddes MRCVS, Senior Product Manager, said: "CPAM is a well-supported initiative and, running it at a time when the media spotlight is already on the dangers of prostate cancer in men, means we can spread the message that owners should also be monitoring older dogs for signs of prostate disease."
Virbac has introduced Odelis CPSE, the first ELISA test to screen for, diagnose and monitor BPH. It is available from three UK diagnostic laboratories. According to the company it is a cost-effective, precise and reliable alternative to rectal palpation. It also offers Ypozane, a tablet treatment for BPH, which takes effect within a week and lasts for six months.
Chris added: "The problem with BPH is that the majority of dogs suffer in silence. It is a painful condition that goes unnoticed until it reaches an advanced stage, where the owner notices blood in the urine or painful urination.
"We're providing practices with all the materials they need to promote the campaign in their locality and hope that those getting involved will find it effective in terms of bringing clients into the practice for advice on BPH. We've also organised coverage in national dog magazines to drive clients to practices."
Practices that diagnose a dog with BPH during CPAM are asked to contact Virbac with details as it plans to collate a series of case studies from the initiative. Love2Shop vouchers to the value of £50 will be provided for the five most pertinent case studies submitted by the end of 2013.
For further information on CPAM, email cpam@virbac.co.uk, contact your Virbac Territory Manager or call the company direct on 01359 243243.
Merial, the manufacturer of FRONTLINE Combo, FRONTLINE Spot On and Merilym3 has announced that Bill Oddie will front its autumn 'Be Tick Aware' PR campaign to highlight the importance of protecting pets from ticks.
The campaign will run throughout September and into October to drive awareness via print, broadcast and digital media.
Merial says the campaign has been designed to raise awareness of ticks and tick-borne diseases amongst vets, pharmacists and SQPs and in turn to educate pet owners on the importance of regularly treating their pets for ticks.
The company is also continuing its partnership with BADA-UK, the tick-borne disease charity whose own demonstration dog, Shaun, recently suffered with Borreliosis (Lyme disease).
BADA-UK founder and Chair, Wendy Fox, said: "The infection highlights the very real risk of contracting tick borne diseases, even for the most well-cared for dogs and tick-aware owners. We find a lot of owners genuinely believe their dogs cannot get ticks because they keep their animals clean and well groomed. This sort of misconception is notable even at canine events where you might expect to encounter the best informed dog owners, but the sad fact is many people still do not take the risk of tick-borne diseases seriously enough."
Roddy Webster Head of Pets UK from Merial said: "It is a pleasure to work with Bill Oddie, a fellow animal lover and expert, to highlight the risk of ticks this autumn. Ticks and tick-borne diseases are an increasing threat, and the risk in the UK is rising. Ticks are considered to be second only to mosquitoes as vectors of infectious diseases around the world. Disease-transmitting ticks can be found anywhere - gardens, forests, parks and even beaches. This campaign is designed to encourage vets, pharmacists and SQPs to educate their clients and customers about ticks, the dangers of tick-borne disease and the importance of regular tick prevention. We're extremely excited about this campaign and we're looking forward to seeing the positive effects."
The RCVS Disciplinary Committee has agreed to adjourn multiple charges against an Essex-based veterinary surgeon who qualified in 1969, following his undertakings firstly to request removal from the RCVS Register and secondly never apply to be restored to it.
At the hearing, which had originally been listed for seven days, Geoffrey Raymond Oliver, 68, was charged with serious professional misconduct over allegations of his inadequate treatment of two dogs and a cat (belonging to three different clients) between 2010 and 2012; inadequate record keeping; failures to deal honestly or properly with his clients; and, failure to heed advice from the RCVS Preliminary Investigation Committee about the importance of proper communication between veterinary surgeons and their clients.
However, before the Committee heard evidence on any aspect of these charges, Mr Oliver lodged his application for adjournment. The Committee therefore made no findings on the charges, and emphasised they had neither been proved against, nor admitted by, him.
The Committee noted that there had been no adverse findings against Mr Oliver during his professional career, that his practice was now closed and that he had no intention of returning to practise in the future. Should he subsequently apply to be restored to the Register, the Committee would resume its consideration of the charges, along with his breach of the undertaking.
The Committee was advised that none of the complainants in the case - which could have incurred considerable time and costs - dissented from the proposed course of action.
Speaking on behalf of the Disciplinary Committee, its Chairman, Professor Peter Lees, said: "The Committee has concluded that no useful purpose would be served were it to insist on a full hearing [and it] would be a disproportionate waste of...resources [to do so]. The Committee is satisfied that [granting the adjournment application] protects the welfare of animals and...is in the public interest."
The Committee then accepted Mr Oliver's undertakings, including the removal of his name from the Register with immediate effect.
Professor Lees added: "So that he is in no doubt about the matter, the Committee reminds [Mr Oliver] that, when referring clients of his former practice elsewhere, he should be careful to avoid giving them any advice about the diagnosis or treatment of their animals."
Zoetis has announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has approved Apoquel (oclacitinib tablet) in the European Union for the treatment of pruritus associated with allergic dermatitis and the treatment of clinical manifestations of atopic dermatitis in dogs at least 12 months of age.
Developed by Zoetis, Apoquel is the first Janus kinase (JAK) inhibitor approved for veterinary use. The company says it inhibits the function of a variety of allergic, itch and pro-inflammatory cytokines dependent on JAK enzyme activity and thus stops the cycle of itch and inflammation occurring in skin allergies.
Michael Stegemann, Senior Director Global Development Organisation at Zoetis said: "Apoquel is a targeted treatment that specifically inhibits JAK-dependent cytokines involved in allergic skin disease in dogs. Its rapid anti-pruritic effect along with its anti-inflammatory properties provide fast relief to dogs. Relief from itch and inflammation is maintained in dogs receiving long-term treatment with Apoquel. This exciting innovation molecule offers quick, effective, and sustained itch relief; improves skin lesions continuously and can be used safely short or long-term."
Zoetis says that in clinical trials, Apoquel demonstrated safety and efficacy for the treatment of itch and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners as soon as 24 hours after administration, the first observation time point, and itch continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinary surgeons were significantly improved after one week and continued to improve long term during the studies (4 months). In these studies, the most common side effects observed in dogs treated with Apoquel were vomiting and diarrhea. Other reported side effects included lethargy, decreased or lack of appetite, skin irritation or infection, and ear irritation or infection.
Apoquel will be a POM-V treatment. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium to long term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
Zoetis plans to make Apoquel available to veterinary surgeons in the European Union during 2014. Meantime, Zoetis says it will be working with vets on the new science and research findings around itch and canine allergic diseases. For more information, visit www.zoetis.com, www.itchcycle.com.
Dechra Veterinary Products has launched Vitamin K1 tablets for dogs, which help reverse the effects of exposure to anticoagulant rodenticides.
The launch of the NFA-VPS licensed 50mg tablets means that veterinary professionals can have a ready supply of Vitamin K when treating animals which have been exposed or may have been exposed to serious poisoning. Previously, the tablets where only available as a special import certificate product following Dechra's acquisition of Eurovet.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Vitamin K1 is an absolutely key therapy in the treatment of potential and accidental exposures to anticoagulant poisoning in animals, mainly in pet dogs. It helps to assist with blood clotting, and the treatment protocol advises continued oral therapy following an initial injectable preparation of Vitamin K.
"The Veterinary Poisons Information Service has received more than 6,000 calls so far this year to its helpline regarding suspected or confirmed poisoning of all types of animals, whether accidental or deliberate exposure.
"We had been able to offer the Vitamin K1 injection and tablets via a SIC, when previously sometimes only preparations for human use were available. Therefore, we are delighted to now launch a licensed tablet which will ensure a ready supply and speed of therapy for animals affected by anticoagulant rodenticides."
Carol added: "Anticoagulant poisoning queries are already the second most common type received by the Veterinary Poisons Information Service, and with the launch of these tablets, veterinary professions will be able to have a ready supply of vitamin K to hand. We would recommend that all practices consider stocking this product."
Vitamin K1 50mg tablets, for the treatment of anticoagulant poisoning following parenteral treatment, are available in boxes of 14 tablets, in blister packs of seven tablets.
For more information, please visit www.dechra.co.uk